APOA1 and type 2 diabetes mellitus: The patients who were autoantibody positive were found to have significantly lower apoA-1 levels (p = 0.02) and higher hsCRP levels (p = 0.04), but there were no significant differences in the CVD prevalence, type 2 diabetes prevalence, statin use, age, other lipid parameters, HbA1c, fasting glucose, HOMA-IR or BMI (Table 2).